PUBLISHER: KBV Research | PRODUCT CODE: 1457272
PUBLISHER: KBV Research | PRODUCT CODE: 1457272
North America Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type, By End User, By Application, By Product Type, By Country and Growth Forecast, 2023 - 2030
The North America Rabies Vaccine Market would witness market growth of 4.0% CAGR during the forecast period (2023-2030).
The US market dominated the North America Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $384.4 Million by 2030. The Canada market is experiencing a CAGR of 6.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.4% during (2023 - 2030).
One key strategy for controlling rabies involves mass vaccination campaigns targeting domestic animals, particularly dogs. Dogs are the main reservoirs of the rabies virus, and widespread vaccination helps to interrupt the transmission cycle between humans and animals. Vaccinating a significant proportion of the canine population can dramatically reduce the incidence of rabies in animals and humans.
Oral rabies vaccination (ORV) is a unique and innovative approach to controlling the spread of rabies in wildlife populations. ORV involves distributing vaccine-laden baits in targeted areas to reach carnivorous wildlife species that may act as reservoirs for the virus. This method has been employed to prevent the spillover of rabies from wildlife to domestic animals and humans, contributing to the overall reduction of rabies cases.
Canada has been actively implementing wildlife rabies control programs, especially in regions where rabies is prevalent among wildlife species such as foxes, raccoons, and bats. The geographical coverage of ORV programs in Canada has expanded over time. Continuous efforts to reach a broader range of wildlife habitats contribute to more extensive control of rabies, reducing the risk of spillover to domestic animals and humans in Canada. ORV is often integrated with other control measures, such as surveillance, pet vaccination campaigns, and public health initiatives in Canada. The comprehensive approach maximizes the impact of rabies control efforts in Canada. Hence, the factors mentioned above will drive the regional market growth.
Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Boehringer Ingelheim International GmbH
- Cadila Pharmaceuticals Limited
- Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Merck & Co., Inc.
- Novartis AG
- Bharat Biotech Ltd.
- Sanofi S.A.
- Virbac
North America Rabies Vaccine Market Report Segmentation
By Prophylaxis Type
- Post-exposure Prophylaxis
- Pre-exposure prophylaxis
By End User
- Hospitals
- Veterinary Clinics
- Others
By Application
- Human
- Animal
By Product Type
- Chick Embryo Cells Rabies Vaccine
- Human Diploid Cell Vaccine
- Vero cell rabies vaccine
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America Rabies Vaccine Market, by Prophylaxis Type
- 1.4.2North America Rabies Vaccine Market, by End User
- 1.4.3North America Rabies Vaccine Market, by Application
- 1.4.4North America Rabies Vaccine Market, by Product Type
- 1.4.5North America Rabies Vaccine Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter Five Forces Analysis
Chapter 4.North America Rabies Vaccine Market by Prophylaxis Type
- 4.1North America Post-exposure Prophylaxis Market by Region
- 4.2North America Pre-exposure prophylaxis Market by Region
Chapter 5.North America Rabies Vaccine Market by End User
- 5.1North America Hospitals Market by Country
- 5.2North America Veterinary Clinics Market by Country
- 5.3North America Others Market by Country
Chapter 6.North America Rabies Vaccine Market by Application
- 6.1North America Human Market by Country
- 6.2North America Animal Market by Country
Chapter 7.North America Rabies Vaccine Market by Product Type
- 7.1North America Chick Embryo Cells Rabies Vaccine Market by Country
- 7.2North America Human Diploid Cell Vaccine Market by Country
- 7.3North America Vero Cell Rabies Vaccine Market by Country
- 7.4North America Others Market by Country
Chapter 8.North America Rabies Vaccine Market by Country
- 8.1US Rabies Vaccine Market
- 8.1.1US Rabies Vaccine Market by Prophylaxis Type
- 8.1.2US Rabies Vaccine Market by End User
- 8.1.3US Rabies Vaccine Market by Application
- 8.1.4US Rabies Vaccine Market by Product Type
- 8.2Canada Rabies Vaccine Market
- 8.2.1Canada Rabies Vaccine Market by Prophylaxis Type
- 8.2.2Canada Rabies Vaccine Market by End User
- 8.2.3Canada Rabies Vaccine Market by Application
- 8.2.4Canada Rabies Vaccine Market by Product Type
- 8.3Mexico Rabies Vaccine Market
- 8.3.1Mexico Rabies Vaccine Market by Prophylaxis Type
- 8.3.2Mexico Rabies Vaccine Market by End User
- 8.3.3Mexico Rabies Vaccine Market by Application
- 8.3.4Mexico Rabies Vaccine Market by Product Type
- 8.4Rest of North America Rabies Vaccine Market
- 8.4.1Rest of North America Rabies Vaccine Market by Prophylaxis Type
- 8.4.2Rest of North America Rabies Vaccine Market by End User
- 8.4.3Rest of North America Rabies Vaccine Market by Application
- 8.4.4Rest of North America Rabies Vaccine Market by Product Type
Chapter 9.Company Profiles
- 9.1Cadila Pharmaceuticals Limited
- 9.1.1Company Overview
- 9.1.2Recent strategies and developments:
- 9.1.2.1Product Launches and Product Expansions:
- 9.2Bharat Biotech Ltd.
- 9.2.1Company Overview
- 9.3Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
- 9.3.1Company Overview
- 9.4Boehringer Ingelheim International GmbH
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional & Segmental Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
- 9.5Elanco Animal Health, Inc.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5SWOT Analysis
- 9.6Zoetis, Inc.
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
- 9.7Merck & Co., Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Segmental and Regional Analysis
- 9.7.4Research & Development Expenses
- 9.7.5SWOT Analysis
- 9.8Novartis AG
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Segmental and Regional Analysis
- 9.8.4Research & Development Expense
- 9.8.5SWOT Analysis
- 9.9Sanofi S.A.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental and Regional Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
- 9.10.Virbac
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4SWOT Analysis
LIST OF TABLES
- TABLE 1North America Rabies Vaccine Market, 2019 - 2022, USD Million
- TABLE 2North America Rabies Vaccine Market, 2023 - 2030, USD Million
- TABLE 3North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
- TABLE 4North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
- TABLE 5North America Post-exposure Prophylaxis Market by Region, 2019 - 2022, USD Million
- TABLE 6North America Post-exposure Prophylaxis Market by Region, 2023 - 2030, USD Million
- TABLE 7North America Pre-exposure prophylaxis Market by Region, 2019 - 2022, USD Million
- TABLE 8North America Pre-exposure prophylaxis Market by Region, 2023 - 2030, USD Million
- TABLE 9North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
- TABLE 10North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
- TABLE 11North America Hospitals Market by Country, 2019 - 2022, USD Million
- TABLE 12North America Hospitals Market by Country, 2023 - 2030, USD Million
- TABLE 13North America Veterinary Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 14North America Veterinary Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 15North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 16North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 17North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
- TABLE 18North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
- TABLE 19North America Human Market by Country, 2019 - 2022, USD Million
- TABLE 20North America Human Market by Country, 2023 - 2030, USD Million
- TABLE 21North America Animal Market by Country, 2019 - 2022, USD Million
- TABLE 22North America Animal Market by Country, 2023 - 2030, USD Million
- TABLE 23North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
- TABLE 24North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
- TABLE 25North America Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
- TABLE 26North America Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
- TABLE 27North America Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
- TABLE 28North America Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
- TABLE 29North America Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
- TABLE 30North America Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
- TABLE 31North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 32North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 33North America Rabies Vaccine Market by Country, 2019 - 2022, USD Million
- TABLE 34North America Rabies Vaccine Market by Country, 2023 - 2030, USD Million
- TABLE 35US Rabies Vaccine Market, 2019 - 2022, USD Million
- TABLE 36US Rabies Vaccine Market, 2023 - 2030, USD Million
- TABLE 37US Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
- TABLE 38US Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
- TABLE 39US Rabies Vaccine Market by End User, 2019 - 2022, USD Million
- TABLE 40US Rabies Vaccine Market by End User, 2023 - 2030, USD Million
- TABLE 41US Rabies Vaccine Market by Application, 2019 - 2022, USD Million
- TABLE 42US Rabies Vaccine Market by Application, 2023 - 2030, USD Million
- TABLE 43US Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
- TABLE 44US Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
- TABLE 45Canada Rabies Vaccine Market, 2019 - 2022, USD Million
- TABLE 46Canada Rabies Vaccine Market, 2023 - 2030, USD Million
- TABLE 47Canada Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
- TABLE 48Canada Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
- TABLE 49Canada Rabies Vaccine Market by End User, 2019 - 2022, USD Million
- TABLE 50Canada Rabies Vaccine Market by End User, 2023 - 2030, USD Million
- TABLE 51Canada Rabies Vaccine Market by Application, 2019 - 2022, USD Million
- TABLE 52Canada Rabies Vaccine Market by Application, 2023 - 2030, USD Million
- TABLE 53Canada Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
- TABLE 54Canada Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
- TABLE 55Mexico Rabies Vaccine Market, 2019 - 2022, USD Million
- TABLE 56Mexico Rabies Vaccine Market, 2023 - 2030, USD Million
- TABLE 57Mexico Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
- TABLE 58Mexico Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
- TABLE 59Mexico Rabies Vaccine Market by End User, 2019 - 2022, USD Million
- TABLE 60Mexico Rabies Vaccine Market by End User, 2023 - 2030, USD Million
- TABLE 61Mexico Rabies Vaccine Market by Application, 2019 - 2022, USD Million
- TABLE 62Mexico Rabies Vaccine Market by Application, 2023 - 2030, USD Million
- TABLE 63Mexico Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
- TABLE 64Mexico Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
- TABLE 65Rest of North America Rabies Vaccine Market, 2019 - 2022, USD Million
- TABLE 66Rest of North America Rabies Vaccine Market, 2023 - 2030, USD Million
- TABLE 67Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
- TABLE 68Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
- TABLE 69Rest of North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
- TABLE 70Rest of North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
- TABLE 71Rest of North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
- TABLE 72Rest of North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
- TABLE 73Rest of North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
- TABLE 74Rest of North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
- TABLE 75Key Information - Cadila Pharmaceuticals Limited
- TABLE 76Key Information - Bharat Biotech Ltd.
- TABLE 77Key Information - Serum Institute of India Pvt. Ltd.
- TABLE 78Key Information - Boehringer Ingelheim International GmbH
- TABLE 79Key information - Elanco Animal Health, Inc.
- TABLE 80Key Information - Zoetis, Inc.
- TABLE 81Key Information - Merck & Co., Inc.
- TABLE 82Key Information - Novartis AG
- TABLE 83Key Information - Sanofi S.A.
- TABLE 84Key Information - Virbac
